Substituted 1,2,4-Triazoles for Selective STING Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for modulating the STING protein, which plays a crucial role in immune responses against infections and tumors, are inadequate in selectively stimulating or inhibiting its activity to treat diseases such as cancer and immunological disorders.
Innovation Solution
Development of substituted 1,2,4-triazole compounds that selectively modulate the STING protein, activating or inhibiting its signaling pathways to stimulate type I interferon production and cytokine release, thereby treating or preventing diseases associated with STING expression or function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used to modulate STING protein, then treatment of diseases is attempted, but selective stimulation or inhibition of STING activity is inadequate
Solution Approach 1:
The patent employs parameter changes by modifying chemical structures of triazole compounds to achieve selective STING modulation. Specific substitutions at positions R1, R2, and R3 of the 1,2,4-triazole core create compounds with optimized binding affinity and selectivity for STING protein, resolving the contradiction between selectivity and therapeutic effectiveness.
Solution Approach 2:
The patent applies local quality by introducing specific functional groups at defined positions on the triazole molecule. The R1, R2, and R3 substituents provide localized chemical properties that interact with specific regions of the STING protein, enabling selective modulation while maintaining overall therapeutic activity.
2Reliability
If substituted 1,2,4-triazole compounds are developed to selectively modulate STING, then immune response stimulation is enhanced, but drug development complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the triazole molecule into distinct functional regions (R1, R2, R3 substituents) that can be independently optimized. This modular approach allows systematic exploration of structure-activity relationships while maintaining a manageable core structure, balancing selectivity achievement with development complexity.
Solution Approach 2:
The patent achieves universality by designing a core 1,2,4-triazole structure that can accommodate multiple different substituent patterns. This universal scaffold enables a series of analogs to be developed from a single platform, reducing overall program complexity while maintaining selective STING modulation capability.
Data Source
AI summary
In an embodiment of the present invention, compounds of the present application or pharmaceutically acceptable salts thereof are capable of interacting with and activating the stimulator of interferon genes (STING) protein. In an embodiment of the present invention, pharmaceutical compositions and methods involving such compounds as STING modulators are additionally provided herein.